U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07674940) titled 'A Trial to Assess TEV-56286 at Different Doses in Healthy Participants' on June 23.
Brief Summary: The purpose of the trial is to evaluate the pharmacokinetics, safety, and tolerability of TEV-56286 at different doses.
The main objective is to describe how TEV-56286 is absorbed, distributed, and removed from the body (the pharmacokinetics) following administration of TEV-56286 in single doses of increasing amounts and multiple doses in healthy participants.
A secondary objective is to assess the safety of TEV-56286 and how well it is tolerated.
The estimated duration for participants in Part 1 with Single Ascending Dose is approxi...